İlaç

Produodopa 240 mg/ml + 12 mg/ml Infüzyonluk Çözelti

Foslevodopa, Foskarbidopa İnfüzyon Reçete durumu belirtilmemiş

Abbvie Tibbi İlaçlar Sanayi ve Ticaret Limited Şirketi

Produodopa 240 mg/ml + 12 mg/ml Infüzyonluk Çözelti Nedir ve Ne İçin Kullanılır?

16/17 3. \0003 \0005 \0002 \000' \0008 \0002 \000' \0002 \0003 \000$ \000 \000? \000Q \000I \000? \000] \000\\ \000R \000Q \000X \000Q \000X \000] \000X \000Q \000 \000$ \000\\ \000D \000U \000O \000D \000Q \000P \000D \000V \000? \000

\000x \000? \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000V \000H \000W \000L \000 \000W \000? \000S \000? \000Q \000? \000 \000\\ \000H \000Q \000L \000 \000H \000Q \000M \000H \000N \000W \000| \000U \000H \000 \000W \000D \000N \000? \000Q \000? \000] \000 \000

  • \000\( \000Q \000M \000H \000N \000W \000| \000U \000? \000 \000V \000? \000N \000? \000F \000D \000 \000W \000X \000W \000D \000U \000N \000H \000Q \000 \000L \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000V \000H \000W \000L \000 \000W \000? \000S \000? \000Q \000? \000 \000H \000Q \000M \000H \000N \000W \000| \000U \000H \000 \000W \000D \000N \000? \000Q \000 \000Y \000H \000 \000V \000? \000N \000? \000 \000R \000O \000D \000Q \000D \000 \000N \000D \000G \000D \000U \000 \000o \000H \000Y \000L \000U \000L \000Q \000L \000] \000 \000 \000
  • \000$ \000\\ \000U \000? \000Q \000W \000? \000O \000? \000 \000W \000D \000O \000L \000P \000D \000W \000O \000D \000U \000 \000L \000o \000L \000Q \000 \000L \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000V \000H \000W \000L \000 \000N \000X \000O \000O \000D \000Q \000? \000P \000 \000W \000D \000O \000L \000P \000D \000W \000O \000D \000U \000? \000Q \000D \000E \000D \000N \000? \000Q \000? \000] \000 \000

\000x \000\( \000Q \000M \000H \000N \000W \000| \000U \000? \000 \000S \000R \000P \000S \000D \000\\ \000D \000 \000\\ \000H \000U \000O \000H \000? \000W \000L \000U \000L \000Q \000L \000] \000 \000 \000

  • \000$ \000\\ \000U \000? \000Q \000W \000? \000O \000? \000 \000W \000D \000O \000L \000P \000D \000W \000O \000D \000U \000 \000L \000o \000L \000Q \000 \0009 \000\\ \000D \000I \000X \000V \000H \000U \000 \000S \000R \000P \000S \000D \000Q \000? \000Q \000 \000N \000X \000O \000O \000D \000Q \000? \000P \000? \000Q \000D \000 \000L \000O \000L \000? \000N \000L \000Q \000 \000K \000D \000V \000W \000D \000 \000W \000D \000O \000L \000P \000D \000W \000O \000D \000U \000? \000Q \000D \000 \000E \000D \000N \000? \000Q \000? \000] \000 \000

\000? \000 \000? \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000V \000H \000W \000L \000 \000W \000? \000S \000? \000Q \000? \000 \000N \000X \000O \000O \000D \000Q \000? \000P \000D \000 \000K \000D \000] \000? \000U \000 \000K \000D \000O \000H \000 \000J \000H \000W \000L \000U \000L \000Q \000L \000] \000 \000 \000+ \000D \000] \000? \000U \000 \000K \000D \000O \000H \000 \000J \000H \000W \000L \000U \000P \000H \000 \000 \000S \000R \000P \000S \000D \000Q \000? \000Q \000 \000K \000D \000W \000W \000D \000N \000L \000 \000K \000D \000Y \000D \000\\ \000? \000 \000o \000? \000N \000D \000U \000P \000D \000N \000 \000L \000o \000L \000Q \000 \000L \000O \000D \000F \000? \000Q \000? \000] \000? \000 \000H \000Q \000M \000H \000N \000W \000| \000U \000G \000H \000Q \000 \000L \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000V \000H \000W \000L \000 \000W \000? \000S \000? \000Q \000H \000 \000L \000W \000P \000H \000V \000L \000 \000D \000Q \000O \000D \000P \000? \000Q \000D \000 \000J \000H \000O \000L \000U \000 \000 \000

  • \000 \000$ \000\\ \000U \000? \000Q \000W \000? \000O \000? \000 \000W \000D \000O \000L \000P \000D \000W \000O \000D \000U \000 \000L \000o \000L \000Q \000 \0009 \000\\ \000D \000I \000X \000V \000H \000U \000 \000S \000R \000P \000S \000D \000Q \000? \000Q \000 \000N \000X \000O \000O \000D \000Q \000? \000P \000? \000Q \000D \000

\000L \000O \000L \000? \000N \000L \000Q \000 \000K \000D \000V \000W \000D \000 \000W \000D \000O \000L \000P \000D \000W \000O \000D \000U \000? \000Q \000D

\000e \000d \000n \000? \000q

\000? \000] .

4. \000? \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000\\ \000H \000U \000L \000Q \000L \000Q \000 \000V \000H \000o \000L \000P \000L \000 \000Y \000H \000 \000K \000D \000] \000? \000U \000O \000D \000Q \000P \000D \000V \000? \000 \000x \000* \000| \000E \000H \000N \000 \000G \000H \000O \000L \000? \000L \000Q \000G \000H \000Q \000 \000H \000Q \000 \000D \000] \000 \000 \000 \000F \000P \000 \000X \000] \000D \000N \000W \000D \000 \000J \000| \000V \000W \000H \000U \000L \000O \000H \000Q \000 \000 \000N \000D \000U \000? \000Q \000 b?lgesinde\ bir b?lge se?iniz. \000x \000< \000D \000U \000D \000O \000? \000 \000F \000L \000O \000W \000O \000H \000U \000G \000H \000Q \000 \000 \000V \000H \000U \000W \000O \000H \000? \000P \000L \000? \000 \000G \000R \000N \000X \000O \000D \000U \000G \000D \000Q \000 \000 \000o \000D \000W \000O \000D \000N \000O \000D \000U \000G \000D \000Q \000 \000Y \000H \000\\ \000D \000 \000Y \000? \000F \000X \000G \000X \000Q \000 \000G \000R \000? \000D \000O \000 \000R \000O \000D \000U \000D \000N \000 \000E \000? \000\\ \000? \000N \000 \000| \000O \000o \000? \000G \0

Sıkça Sorulan Sorular

Produodopa 240 mg/ml + 12 mg/ml Infüzyonluk Çözelti ne için kullanılır?
16/17 3. \0003 \0005 \0002 \000' \0008 \0002 \000' \0002 \0003 \000$ \000 \000? \000Q \000I \000? \000] \000\\ \000R \000Q \000X \000Q \000X \000] \000X \000Q \000 \000$ \000\\ \000D \000U \000O \000D \000Q \000P \000D \000V \000? \000 \000x \000? \000Q \000I \000? \000] \000\\ \000R \000Q \000 \000V \000H \000W \000L \000 \000W \000? \000S \000? \000Q \000? \000 \000\\ \000H \000Q \000L \000 \000H \000Q \000M \000H \000N \000W \000| \000U \000H \000 \000W \000D \000N \000?
Kaynak: T.C. Sağlık Bakanlığı TİTCK Kısa Ürün Bilgisi & Kullanma Talimatı. Bu içerik yalnızca bilgilendirme amaçlıdır, hekim tavsiyesi yerine geçmez.

Önemli Uyarı: Bu sayfadaki bilgiler yalnızca bilgilendirme amaçlıdır ve tıbbi tavsiye yerine geçmez. İlaç kullanımı konusunda mutlaka doktorunuza veya eczacınıza danışınız. Kendi başınıza ilaç başlatmayın, değiştirmeyin veya bırakmayın. Kaynak: T.C. Sağlık Bakanlığı TİTCK.